Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Keratosis, Actinic 22Carcinoma, Basal Cell 10Uterine Cervical Dysplasia 7Melanoma 7Breast Neoplasms 4Uterine Cervical Neoplasms 3Precancerous Conditions 3Keratosis 3Glioma 3Glioblastoma 3Condylomata Acuminata 3Urinary Bladder Neoplasms 2Squamous Intraepithelial Lesions 2Papillomavirus Infections 2Non-Muscle Invasive Bladder Neoplasms 2Neoplasm Metastasis 2Hutchinson's Melanotic Freckle 2HIV Infections 2Astrocytoma 2Warts 1Vulvar Neoplasms 1Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1Virus Diseases 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sialorrhea 1Sexually Transmitted Diseases 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Surveys and Questionnaires 1Lymph Node Excision 1Interferon-alpha 1Imiquimod 13-ingenyl angelate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Facies × Imiquimod × Clear all
NCT00581425 2013-01-25

Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)

The University of Texas Health Science Center, Houston

Phase 4 Completed
49 enrolled
Dermatologic

Carcinoma, Basal Cell, Facies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡